Vor Biopharma Q1 2026 Earnings Wide EPS Miss Sends Stock Down 47 Amid Ongoing Clinical Development RadNet Inc RDNT Q1 2026 Earnings WiderThanExpected Loss Weighs on Shares SERV Q1 2026 Earnings EPS Falls Short of Estimates Amid PreRevenue Phase JOB Q4 2025 Earnings EPS Misses Estimates Stock Edges Higher FSEA Q3 2024 Earnings Positive EPS of 001 Marks Operational Stability Bicara Therapeutics BCAX Q1 2026 Earnings ClinicalStage Biotech Reports WiderthanExpected Loss Shares Rise